Drugs / Mepivacaine 2% Injection
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07696156 Background | Jan 2027 → Jan 2028 expected | anxiety | diana garcia | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mepivacaine 2% Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07696156 ↗ |
| Route | Subcutaneous | “Subcutaneous local anesthetic administered at the puncture site prior to vein needle insertion to minimize procedural pain” NCT07696156 ↗ |